Advertisement
In conjunction with the issuance of the press release, Idenix managementwill host a conference call at 4:30 p.m. ET on Tuesday, November 6, 2007 todiscuss the company's financial results for the third quarter 2007.
Advertisement
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475International and enter passcode 21545602 or to listen to a live audio webcastof the call, go to "Calendar of Events" in the Idenix Investor Center athttp://www.idenix.com. A replay of the call will also be available from 5:30p.m. ET on November 6, 2007 until 11:30 p.m. ET on November 20, 2007. Toaccess the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291International and enter passcode 21545602. An archived webcast will also beavailable for two weeks after the call on the Idenix website.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,is a biopharmaceutical company engaged in the discovery, development andcommercialization of drugs for the treatment of human viral and otherinfectious diseases. Idenix's current focus is on the treatment of infectionscaused by the hepatitis C virus and HIV. For further information about Idenix,please refer to http://www.idenix.com.
Idenix Pharmaceuticals' Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
SOURCE Idenix Pharmaceuticals, Inc.
